A 12-month role-over study to evaluate the efficacy of sustain release formulation of human recombinant growth hormone (Eutropin Plus) as compared to standard daily rhGH (Eutropin) in prepubertal children with growth hormone deficiency.
Phase of Trial: Phase II
Latest Information Update: 29 Nov 2015
At a glance
- Drugs Somatropin (Primary) ; Somatropin
- Indications Somatotropin deficiency
- Focus Therapeutic Use
- 29 Nov 2015 New trial record